Sort
39,280 grants matching “leukemia”
Enhancing cytarabine efficacy in leukemia through CDK8/19 inhibition
$299,891Donald C. Porter · Senex Biotechnology, Inc. · R43 · FY2017 · CA
Development and Applications of 'Designer Chromatin'
$299,888Tom W Muir · Princeton University · R01 · FY2014 · GM
Molecular concepts that monitor methionine metabolism
$299,883Peter Kaiser · University Of California-Irvine · R01 · FY2021 · GM
MECHANISM(S) OF CHEMICAL LEUKEMOGENESIS
$299,880University Of Colorado Denver · R01 · FY2002 · ES
Retrovirus Assembly and Maturation
$299,875Alan Rein · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Human T cell Lymphotropic Virus Vaccine development
$299,860Glen N Barber · Stinginn, Llc · R41 · FY2022 · AI
Development of a dual MDM2/XIAP inhibitor with a high therapeutic index for childhood cancers
$299,823Zhongzhi Wu · Seak Therapeutics, Llc · R43 · FY2019 · CA
Role of PBX Proteins in Hematopoiesis and Growth Control
$299,800Michael L Cleary · Stanford University · R01 · FY2008 · CA
Eastern Cooperative Oncology Group
$299,793Indiana Univ-Purdue Univ At Indianapolis · U10 · FY2004 · CA
Development of a Universal Assay for Minimal Residual Disease in Acute Myeloid Leukemia using Duplex Sequencing
$299,790Jesse J Salk · Twinstrand Biosciences, Inc. · R44 · FY2018 · CA
Human Tumor Analyses
$299,789William M Grady · University Of Washington · P01 · FY2011 · CA
INK4 FAMILY OF CDK INHIBITORS
$299,786University Of North Carolina Chapel Hill · R01 · FY2001 · CA
Pharmacological rejuvenation of human hematopoietic stem cells
$299,781James C Mulloy · Mogling Bio Inc · R43 · FY2024 · HL
Regulators of Cancer-Specific DNA Hypermethylation.
$299,720Jean-Pierre J Issa · Temple Univ Of The Commonwealth · R01 · FY2013 · CA
Novel Roles of p53 & ROS in Therapy of Refractory CLL
$299,699Peng Huang · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA
Novel Roles of p53 & ROS in Therapy of Refractory CLL
$299,699Peng Huang · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA
Tumor-toxic CD47 mAb therapy for leukemia: a proof of concept study
$299,687William A Frazier · Vasculox, Inc. · R41 · FY2013 · CA
Methodology for Identification of Substrate-Competitive Kinase Inhibitors
$299,667Matthew B Soellner · University Of Michigan At Ann Arbor · R01 · FY2009 · GM
Development of a chemically regulated immunotherapy for B-cell malignancies
$299,600Erin Forbes Simonds · Soteria Biotherapeutics, Inc. · R43 · FY2019 · CA
Role of PBX Proteins in Hematopoiesis and Growth Control
$299,598Michael L Cleary · Stanford University · R01 · FY2007 · CA
Regulation of hematopoietic stem cell differentiation
$299,591Iannis Aifantis · New York University School Of Medicine · R01 · FY2012 · CA
Regulation of hematopoietic stem cell differentiation
$299,591Iannis Aifantis · New York University School Of Medicine · R01 · FY2011 · CA
Genomics of Acute Myelogenous Leukemia (AML): Relapse and Resistance Factors
$299,591John F Dipersio · Washington University · P01 · FY2010 · CA
Pathobiology of Cancer at the Host and Population Level
$299,581Laurie H Glimcher · Harvard School Of Public Health · T32 · FY2011 · CA
EAGER: Biomanufacturing the hematopoietic stem cell niche
$299,578Brendan Harley · University Of Illinois At Urbana-Champaign · · FY2015 · ENG